By Josh White
Date: Wednesday 14 May 2025
(Sharecast News) - Niox Group reported strong trading in the first four months of 2025 on Wednesday, with group sales rising 21% year-on-year, supported by continued momentum in its clinical business and a sharp increase in research revenues.
Niox ends sale process as Keensight steps back | 11-Apr-2025 | ShareCast |
Niox reports solid set of full-year results | 01-Apr-2025 | ShareCast |
Niox confirms approach from Keensight, enters fo... | 20-Mar-2025 | ShareCast |
Niox flags strong year, announces board changes | 16-Jan-2025 | ShareCast |
Niox reports solid first-half performance | 24-Sep-2024 | ShareCast |
Holding(s) in Company | 17-Jun-2025 | 11:45 | RNS |
Total Voting Rights | 02-Jun-2025 | 07:00 | RNS |
Holding(s) in Company | 28-May-2025 | 13:19 | RNS |
Change of Adviser | 27-May-2025 | 10:00 | RNS |
Holding(s) in Company | 23-May-2025 | 10:22 | RNS |
Circassia raises £200m in landmark biotech IPO | 14-Mar-2014 | The Independent |
Cat allergy group raises £200m in float | 14-Mar-2014 | Telegraph |
No recent information was found.
No recent information was found.
Currency | UK Pounds |
Share Price | 64.00p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 76.00 |
52 Week Low | 54.60 |
Volume | 45,771 |
Shares Issued | 417.42m |
Market Cap | £267.15m |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Strong Buy | 3 |
Buy | 1 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 4 |
Latest | Previous | |
---|---|---|
Final | Final | |
Ex-Div | 15-May-25 | 23-May-24 |
Paid | 16-Jun-25 | 24-Jun-24 |
Amount | 1.25p | 1.00p |
Time | Volume / Share Price |
16:35 | 1,494 @ 64.00p |
16:35 | 75 @ 64.00p |
16:35 | 16 @ 64.00p |
16:35 | 468 @ 64.00p |
16:35 | 373 @ 64.00p |
You are here: research